List of Tables
    Table 1. Prescription Dermatological Medications CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Prescription Dermatological Medications Market Trends
    Table 3. Prescription Dermatological Medications Market Drivers
    Table 4. Prescription Dermatological Medications Market Challenges
    Table 5. Prescription Dermatological Medications Market Restraints
    Table 6. Global Prescription Dermatological Medications Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Prescription Dermatological Medications Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Prescription Dermatological Medications Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Prescription Dermatological Medications Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Prescription Dermatological Medications Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Prescription Dermatological Medications Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Prescription Dermatological Medications Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Prescription Dermatological Medications Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Prescription Dermatological Medications Sales Share by Manufacturer, 2017-2022
    Table 15. Global Prescription Dermatological Medications Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Prescription Dermatological Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Prescription Dermatological Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Dermatological Medications as of 2021)
    Table 18. Top Players of Prescription Dermatological Medications in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Prescription Dermatological Medications Product Type
    Table 20. Date of International Manufacturers Enter into Prescription Dermatological Medications Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Prescription Dermatological Medications Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Prescription Dermatological Medications Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Prescription Dermatological Medications Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Prescription Dermatological Medications Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Prescription Dermatological Medications Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Prescription Dermatological Medications Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Prescription Dermatological Medications Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Prescription Dermatological Medications Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Prescription Dermatological Medications Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Prescription Dermatological Medications Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Prescription Dermatological Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Prescription Dermatological Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Prescription Dermatological Medications Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Prescription Dermatological Medications Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Prescription Dermatological Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Prescription Dermatological Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Prescription Dermatological Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Prescription Dermatological Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Prescription Dermatological Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Prescription Dermatological Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Mylan Pharmaceuticals Corporation Information
    Table 43. Mylan Pharmaceuticals Description and Business Overview
    Table 44. Mylan Pharmaceuticals Prescription Dermatological Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Mylan Pharmaceuticals Prescription Dermatological Medications Product
    Table 46. Mylan Pharmaceuticals Recent Development
    Table 47. Pfizer Corporation Information
    Table 48. Pfizer Description and Business Overview
    Table 49. Pfizer Prescription Dermatological Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Pfizer Product
    Table 51. Pfizer Recent Development
    Table 52. Almirall Corporation Information
    Table 53. Almirall Description and Business Overview
    Table 54. Almirall Prescription Dermatological Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Almirall Product
    Table 56. Almirall Recent Development
    Table 57. Bausch Health Corporation Information
    Table 58. Bausch Health Description and Business Overview
    Table 59. Bausch Health Prescription Dermatological Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Bausch Health Product
    Table 61. Bausch Health Recent Development
    Table 62. Barrier Therapeutics Corporation Information
    Table 63. Barrier Therapeutics Description and Business Overview
    Table 64. Barrier Therapeutics Prescription Dermatological Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Barrier Therapeutics Product
    Table 66. Barrier Therapeutics Recent Development
    Table 67. PharmaDerm Corporation Information
    Table 68. PharmaDerm Description and Business Overview
    Table 69. PharmaDerm Prescription Dermatological Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. PharmaDerm Product
    Table 71. PharmaDerm Recent Development
    Table 72. Bristol-Myers Squibb Corporation Information
    Table 73. Bristol-Myers Squibb Description and Business Overview
    Table 74. Bristol-Myers Squibb Prescription Dermatological Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Bristol-Myers Squibb Product
    Table 76. Bristol-Myers Squibb Recent Development
    Table 77. Galderma Corporation Information
    Table 78. Galderma Description and Business Overview
    Table 79. Galderma Prescription Dermatological Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Galderma Product
    Table 81. Galderma Recent Development
    Table 82. Novartis Corporation Information
    Table 83. Novartis Description and Business Overview
    Table 84. Novartis Prescription Dermatological Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Novartis Product
    Table 86. Novartis Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Prescription Dermatological Medications Customers List
    Table 90. Prescription Dermatological Medications Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Prescription Dermatological Medications Product Picture
    Figure 2. Global Prescription Dermatological Medications Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Prescription Dermatological Medications Market Size 2017-2028 (US$ Million)
    Figure 4. Global Prescription Dermatological Medications Sales 2017-2028 (K Units)
    Figure 5. United States Prescription Dermatological Medications Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Prescription Dermatological Medications Market Size 2017-2028 (US$ Million)
    Figure 7. United States Prescription Dermatological Medications Sales 2017-2028 (K Units)
    Figure 8. United States Prescription Dermatological Medications Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Prescription Dermatological Medications Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Prescription Dermatological Medications Report Years Considered
    Figure 11. Product Picture of Oral
    Figure 12. Product Picture of Topical
    Figure 13. Global Prescription Dermatological Medications Market Share by Type in 2022 & 2028
    Figure 14. Global Prescription Dermatological Medications Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Prescription Dermatological Medications Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Prescription Dermatological Medications Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Prescription Dermatological Medications Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Prescription Dermatological Medications Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Prescription Dermatological Medications Market Share by Type in 2022 & 2028
    Figure 20. United States Prescription Dermatological Medications Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Prescription Dermatological Medications Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Prescription Dermatological Medications Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Prescription Dermatological Medications Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Prescription Dermatological Medications Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Hospital Pharmacies
    Figure 26. Product Picture of Online Pharmacies
    Figure 27. Product Picture of Retail Pharmacies
    Figure 28. Global Prescription Dermatological Medications Market Share by Application in 2022 & 2028
    Figure 29. Global Prescription Dermatological Medications Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Prescription Dermatological Medications Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Prescription Dermatological Medications Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Prescription Dermatological Medications Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Prescription Dermatological Medications Price by Application (2017-2028) & (USD/Unit)
    Figure 34. United States Prescription Dermatological Medications Market Share by Application in 2022 & 2028
    Figure 35. United States Prescription Dermatological Medications Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Prescription Dermatological Medications Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Prescription Dermatological Medications Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Prescription Dermatological Medications Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Prescription Dermatological Medications Price by Application (2017-2028) & (USD/Unit)
    Figure 40. North America Prescription Dermatological Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Prescription Dermatological Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Prescription Dermatological Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Prescription Dermatological Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Prescription Dermatological Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Prescription Dermatological Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Prescription Dermatological Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Prescription Dermatological Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Prescription Dermatological Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Prescription Dermatological Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Prescription Dermatological Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Prescription Dermatological Medications Value Chain
    Figure 74. Prescription Dermatological Medications Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed